Procter & Gamble CoPG:NYQ

80.60
0.40 / 0.49 %
9.19m
0.99 %
0.4346
Close in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Apr 27 2015 21:01 BST.

Consensus recommendation

As of Apr 27, 2015, the consensus forecast amongst 24 polled investment analysts covering Procter & Gamble Co advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Apr 27, 2015. The previous consensus forecast advised that Procter & Gamble Co would outperform the market.

Previous recommendations
Last year3 months ago2 months ago4 weeks agoLatest
Mouseover chart recommendation details.
Latest recommendation
Buy5
Outperform4
Hold14
Underperform1
Sell0
No opinion0

Share price forecast

The 16 analysts offering 12 month price targets for Procter & Gamble Co have a median target of 88.00, with a high estimate of 105.00 and a low estimate of 81.00. The median estimate represents a 9.18% increase from the last price of 80.60. View Full Financials

High+30.3 %105.00
Med+9.2 %88.00
Low+0.5 %81.00

Dividends

In 2014, Procter & Gamble Co reported a dividend of 2.45 USD, which represents a 7.02% increase over last year. The 13 analysts covering the company expect dividends of 2.60 USD for the upcoming fiscal year, an increase of 6.12%. View Full Financials

Div growth (TTM)+7.02 %
  • Mouseover chart for details.
  • Dividend forecast
  • Quarter 1
  • Quarter 2
  • Quarter 3
  • Quarter 4

Earnings history & estimates

On Apr 23, 2015, Procter & Gamble Co reported 3rd quarter 2015 earnings of 0.92 per share. This result was in line with the consensus of the 19 analysts following the company and under-performed last year's 3rd quarter results by 11.54 %. View Full Interim Financials

Average growth rate-2.54 %

Procter & Gamble Co reported annual 2014 earnings of 4.22 per share on Aug 01, 2014. View Full Annual Financials

Average growth rate+0.74 %
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement

Revenue

The Procter & Gamble Company had 3rd quarter 2015 revenues of 18.14bn. This missed the 18.49bn consensus estimate of the 16 analysts following the company. This was 10.01 % below the prior year's 3rd quarter results. View Full Interim Financials

Average growth rate-2.96 %

The Procter & Gamble Company had revenues for the full year 2014 of 83.06bn. This was 1.31 % below the prior year's results. View Full Annual Financials

Average growth rate+1.30 %
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.